Tag | Content |
---|
EnhancerAtlas ID | HS094-06390 |
Organism | Homo sapiens |
Tissue/cell | hMADS-3 |
Coordinate | chr11:6639060-6640000 |
Target genes | Number: 16 | Name | Ensembl ID |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
NFAT5 | MA0606.1 | chr11:6639296-6639306 | ATTTTCCATT | + | 6.02 | NFATC1 | MA0624.1 | chr11:6639296-6639306 | ATTTTCCATT | + | 6.02 | NFATC3 | MA0625.1 | chr11:6639296-6639306 | ATTTTCCATT | + | 6.02 | Pou2f3 | MA0627.1 | chr11:6639370-6639386 | TCAAATTTGCATACTT | - | 6.53 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_09637 | chr11:6620372-6642742 | CD14 | SE_56702 | chr11:6636693-6641303 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CCCTTTTGGA CCTCAACTAT GAGACATCAG GACTTCCCAA AGCCTGGAAC AGGGTAAAGG 60 AGGGCTATGT GTGCAGGTGT AGGGTGTACT TGGGAAGCAG AGGAAGAAAA GGCTGGAGAG 120 ACTTGAAATG CCATGGCCAA TAATATGGAT TTACCCTAAA GGCCAGTAAG TTGCAAATGT 180 CGCACCACAG CATGTATTGC CATGATCATG AAAATGAATG AGGTTAATAC ATATAAATTT 240 TCCATTTTAA TTTTAAGCTT ATGTCCGGTA AATGTTTTCA AATCTTTCGG TACCAGTTAT 300 TCAGTTTAGC TCAAATTTGC ATACTTGTTG ATTTTAAGCT TAACACGATG GTGAGTCACT 360 GTTTCCTGCC ATGCACACTA GTGTCACACT GCCCCGTCCC CAGCCTCTGC AGTTCACAAG 420 CACACACTCC CCCTGCTGTG AAGGGCTTTA ACCAGGAGAA GGAACCAATC CATTTTGACT 480 GTTGGAGAGA CTGTTTTGAA GCAGAGTGGG GGAGTACAGT GAGGGGTGGG GTGGAGGGAG 540 GAGACTGCAG ATCAGCTGGG GAGCTGGGCA GTAGTCCAGG AGTGGGAATA AATAACGGAG 600 TTGGTCGTAA CAAAAGACGG CAAGAAGGAG ATTAATCCAA AGGCTCTTTG GGAGTTAGAA 660 CTGGCAGCCT TAGTATGTGA ACAAAAGAGG AAATTAGAAT GGATTTGAGG GTAGGGGAAG 720 GAACGTAAGT TGTACTAGAT GCCTGGTAGC TAGTAAGTAG CAGAGTCAGA ATTTGAGTTC 780 GTATTTGATC ATAAAGCCTG TATACTGAAC CACATCCCCT TTTAGGTTTC TAGCCTGAGG 840 AACACAAGTG TCTTGGCAGG CTCTGACATG ATCGCCATCC CATGCCCAAC CCAGCCCTGT 900 GTCCCTCCAC CGCATCCCAC ATCCTGTCCT CAGTCCCAAA 940
|